MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Integra LifeSciences Holdings Corp

Затворен

СекторЗдравеопазване

20.12 -7.62

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

20.05

Максимум

21.72

Ключови измерители

By Trading Economics

Приходи

30M

19M

Продажби

62M

443M

P/E

Средно за сектора

63.02

63.778

EPS

0.97

Марж на печалбата

4.391

Служители

4,396

EBITDA

40M

79M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+19.38% upside

Дивиденти

By Dow Jones

Следващи печалби

5.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-343M

1.7B

Предишно отваряне

27.74

Предишно затваряне

20.12

Настроения в новините

By Acuity

50%

50%

180 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.05.2024 г., 16:47 ч. UTC

Печалби
Значими двигатели на пазара

Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings

Сравнение с други в отрасъла

Ценова промяна

Integra LifeSciences Holdings Corp Прогноза

Ценова цел

By TipRanks

19.38% нагоре

12-месечна прогноза

Среден 26 USD  19.38%

Висок 35 USD

Нисък 20 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Integra LifeSciences Holdings Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

7 ratings

2

Купи

3

Задържане

2

Продай

Техническа оценка

By Trading Central

21.69 / 22.3Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

180 / 386 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.